Insider Transactions in Q2 2022 at Adaptimmune Therapeutics PLC (ADAP)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2022
|
Adrian Rawcliffe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,562
-43.78%
|
$2,562
$1.63 P/Share
|
|
May 20
2022
|
Gavin Wood Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
39,000
+28.89%
|
$0
$0.29 P/Share
|